The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Infectious Disease Molecular Diagnostics Market At The End Of The 2026–2030 Forecast Period?
The infectious disease molecular diagnostics market size has exhibited robust growth in recent years. It is anticipated to expand from $30.46 billion in 2025 to $32.04 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.2%. This historical advancement can be attributed to the rising occurrence of infectious diseases, innovations in PCR and sequencing technologies, increased government investment in infectious disease research, heightened awareness regarding early diagnosis, and the proliferation of clinical laboratories.
The infectious disease molecular diagnostics market is projected to experience consistent expansion in the coming years. This market is anticipated to reach $38.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this growth during the projected period include the increasing integration of AI-powered diagnostic instruments, a heightened need for quick and precise diagnostic methods, the improvement of healthcare infrastructure in developing economies, a greater emphasis on individualized medical treatments, and the proliferation of at-home molecular diagnostic products. Key trends anticipated for the forecast timeframe encompass the widespread embrace of rapid point-of-care diagnostics, an escalating requirement for multiplex testing capabilities, the incorporation of molecular diagnostics into electronic health record (EHR) systems, the broadening of infectious disease monitoring initiatives, and a stronger emphasis on identifying antimicrobial resistance.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25793&type=smp
What Drivers Are Shaping The Future Growth Of The Infectious Disease Molecular Diagnostics Market?
The future expansion of the infectious disease molecular diagnostics market is anticipated to be spurred by the growing occurrence of infectious diseases. These illnesses originate from pathogenic microbes like bacteria, viruses, fungi, or parasites, transferable either directly or indirectly between individuals. A primary factor behind the increased incidence of infectious diseases is globalization and the rise in travel, which allows disease-causing agents to quickly disseminate globally, transforming local outbreaks into worldwide health crises. Infectious disease molecular diagnostics aid in managing these conditions by providing swift and precise identification of pathogens at their genetic level, thus assisting in prompt diagnosis, focused therapies, and successful containment of outbreaks. As an illustration, in November 2024, the US Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that tuberculosis (TB) cases in 2023 totaled 9,633, an increase from 8,332 in 2022, representing a 15.6% rise in the number of cases. Consequently, the rising frequency of infectious diseases is fostering the development of the infectious disease molecular diagnostics market.
What Segment Types Make Up The Infectious Disease Molecular Diagnostics Market?
The infectious disease molecular diagnostics market covered in this report is segmented –
1) By Product Type: Kits And Reagents, Instruments, Software And Services
2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Sequencing-Based Molecular Diagnostics, Transcription Mediated Amplification, Other Technologies
3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications
4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes
Subsegments:
1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits
2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers
3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services
Which Market Trends Are Creating New Opportunities In The Infectious Disease Molecular Diagnostics Market?
Major companies within the infectious disease molecular diagnostics market are focusing on developing innovative solutions, such as real-time polymerase chain reaction kits, to enable rapid, accurate, and high-throughput detection of infectious pathogens. Real-time polymerase chain reaction (PCR) kits are diagnostic tools that amplify and simultaneously detect specific genetic material of pathogens in real time, allowing for rapid and accurate identification of infectious diseases. For instance, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences company, launched Applied Biosystems TaqPath polymerase chain reaction kits designed for the detection of infectious diseases in India. These kits are fast, highly sensitive multiplex diagnostic solutions that enable real-time polymerase chain reaction detection of infectious disease targets using a complete workflow from ribonucleic acid extraction to diagnostic report generation, typically in under 4 hours. These kits feature multiplexed assays targeting multiple genomic regions of pathogens, include internal process controls, and provide automated data interpretation, reducing user error and enhancing result reliability.
Who Are The Key Players Driving Competition In The Infectious Disease Molecular Diagnostics Market?
Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.
Read the full infectious disease molecular diagnostics market report here:
Which Geographic Regions Are Influencing Demand In The Infectious Disease Molecular Diagnostics Market?
North America was the largest region in the infectious disease molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Infectious Disease Molecular Diagnostics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25793&type=smp
Browse Through More Reports Similar to the Global Infectious Disease Molecular Diagnostics Market 2026, By The Business Research Company
Infection Control Market Report 2026
https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report
Infection Prevention Market Report 2026
https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report
Hospital Acquired Infection Control Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model